ECSP992991A - NEW HETERO-CYCLE CONCEPTS, THEIR FORMULATION AND USE AS PHARMACEUTICAL PRODUCTS - Google Patents
NEW HETERO-CYCLE CONCEPTS, THEIR FORMULATION AND USE AS PHARMACEUTICAL PRODUCTSInfo
- Publication number
- ECSP992991A ECSP992991A ECSP992991A ECSP992991A EC SP992991 A ECSP992991 A EC SP992991A EC SP992991 A ECSP992991 A EC SP992991A EC SP992991 A ECSP992991 A EC SP992991A
- Authority
- EC
- Ecuador
- Prior art keywords
- formulation
- pharmaceutical products
- new hetero
- concepts
- cycle
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229940127557 pharmaceutical product Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un compuesto de fórmula (I): (gráfico), donde X e Y son independientemente CH, N ó N-óxido, siempre que X e Y no representen ambos CH; Z es CO ó CS; R1 es alquilo, opcionalmente sustituido con uno o más halógenos; y R2, R3, R4 y R5 son, cada uno, diversos grupos orgánicos. Estos compyestos tienen utilidad terapéutica, por inhibición de la fosfodiesterasa IV.A compound of formula (I): (graph), where X and Y are independently CH, N or N-oxide, provided that X and Y do not both represent CH; Z is CO or CS; R1 is alkyl, optionally substituted with one or more halogens; and R2, R3, R4 and R5 are each various organic groups. These compounds have therapeutic utility, by inhibition of phosphodiesterase IV.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992991 ECSP992991A (en) | 1999-06-08 | 1999-06-08 | NEW HETERO-CYCLE CONCEPTS, THEIR FORMULATION AND USE AS PHARMACEUTICAL PRODUCTS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP992991 ECSP992991A (en) | 1999-06-08 | 1999-06-08 | NEW HETERO-CYCLE CONCEPTS, THEIR FORMULATION AND USE AS PHARMACEUTICAL PRODUCTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP992991A true ECSP992991A (en) | 1999-10-06 |
Family
ID=42043980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP992991 ECSP992991A (en) | 1999-06-08 | 1999-06-08 | NEW HETERO-CYCLE CONCEPTS, THEIR FORMULATION AND USE AS PHARMACEUTICAL PRODUCTS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP992991A (en) |
-
1999
- 1999-06-08 EC ECSP992991 patent/ECSP992991A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016762A1 (en) | 4-BROMO OR 4-IODINE PHENYLAMINE BENZOHIDROXAMIC ACID COMPOUNDS, PHARMACEUTICAL FORMULATIONS AND USE OF THE SAME | |
| ECSP045229A (en) | PIRIDINONES REPLACED AS MODULATORS OF THE P38 MAP QUINASA | |
| BR0213140A (en) | Pyrazolopyrimidine fungicides | |
| BR0312560A (en) | New tricyclic spiropiperidines or spiropyrrolidines | |
| BR0014352A (en) | Spirocyclic ketoenols replaced by trifluoromethyl | |
| ATE301653T1 (en) | PYRAZOLOPYRIDINES | |
| ES2127946T3 (en) | DIAZABYCLIC NEUROCININE ANTAGONISTS. | |
| HRP20070510T3 (en) | BENZIMIDAZOL DERIVATIVES AND THEIR USE AS ANTAGONIST II RECEPTORS | |
| ES2171040T3 (en) | DERIVATIVES OF HYDROXYACETIC ESTERS AND ITS USE AS SYNTHESIS INTERMEDIARIES. | |
| ECSP099394A (en) | DERIVATIVES OF QUINUCLIDINOL AS ANTOGONISTS OF MUSCARINIC RECEPTORS | |
| PT1412354E (en) | TRIAZOLYL-IMIDAZOPYRIDINE AND TRIAZOLYLURIN DERIVATIVES USING ADENOSIN A2A RECEPTOR LIGANDS AND THEIR USE AS MEDICINES | |
| BRPI0408353A (en) | compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound | |
| ATE300541T1 (en) | PYRAZOLOPYRIDINE DERIVATIVES | |
| UY27851A1 (en) | DIFENILAZETIDINONAS REPLACED IN RING, PROCEDURE FOR PREPARATION, MEDICATIONS UNDERSTANDING THESE COMPOUNDS AND THEIR USE. | |
| ATE175661T1 (en) | BENZAMIDE DERIVATIVES AS VASOPRESSIN ANTAGONISTS | |
| UY24010A1 (en) | NEW PYROLLOCARBAZOLES | |
| ES2177058T3 (en) | ETER PIPERIDINYLAMINOMETIL TRIFLUOROMETIL CYCLES COMPOUNDS AS AN SUBGONIST OF THE SUBSTANCE P. | |
| DE60318826D1 (en) | ALKOXYPYRIDINDERIVATE | |
| UY27685A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
| ES2132882T3 (en) | 1-ARYL-2-ACILAMINO-ETHANE COMPOUNDS AND THEIR USE AS NEUROQUININE ANTAGONISTS 1. | |
| CO5080802A1 (en) | NEW INHIBITING HETEROCICLICAL COMPOUNDS OF PHOSPHODESTERESA IV AND ITS FORMULATION AND USE AS PHARMACEUTICAL PRODUCTS | |
| CR7249A (en) | DERIVATIVES OF DIAMINE, PROCESS TO PRODUCE THE DERIVATIVES OF DIAMINE, AND FUNGUICIDES CONTAINING THE DERIVATIVES OF DIAMINE AS ACTIVE INGREDIENT | |
| DE60121587D1 (en) | CYCLIC GMP SPECIFIC PHOSPHODIESTERASE INHIBITORS | |
| HUP0004590A2 (en) | Endothelin antagonist imidazole derivatives and beta receptor blocking agents as combined pharmaceutical preparations | |
| ECSP003761A (en) | SILKED HETEROCICLIC COMPOUNDS |